Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000189

Chairperson & CEO sold 9,500 shares at an average $592.42 ($5,627,991)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

13 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-13 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-11-13 Sale : show line 2 in the form 10b5-1 −528 $587.42 $310,156 333,415 I
2026-11-13 Sale : show line 3 in the form 10b5-1 −493 $588.61 $290,183 332,922 I
2026-11-13 Sale : show line 4 in the form 10b5-1 −603 $589.80 $355,647 332,319 I
2026-11-13 Sale : show line 5 in the form 10b5-1 −1,657 $590.65 $978,702 330,662 I
2026-11-13 Sale : show line 6 in the form 10b5-1 −2,181 $591.56 $1,290,198 328,481 I
2026-11-13 Sale : show line 7 in the form 10b5-1 −518 $592.61 $306,973 327,963 I
2026-11-13 Sale : show line 8 in the form 10b5-1 −245 $593.81 $145,483 327,718 I
Open-market sales · 9,500 sh · avg $592.42 · $5,627,991

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-13 Exercise or conversion : show line 14 in the form 10b5-1 Stock Option −9,500 24,410 I
Loading xslF345X06/primarydocument.xml…